EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, 2seventy bio's enterprise value is $270.0 Mil.
2seventy bio's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $100.4 Mil. Therefore, 2seventy bio's EV-to-Revenue for today is 2.69.
The historical rank and industry rank for 2seventy bio's EV-to-Revenue or its related term are showing as below:
TSVT'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.69 Med: 4.35 Max: 20.83
Current: 2.69
During the past 6 years, the highest EV-to-Revenue of 2seventy bio was 20.83. The lowest was 0.69. And the median was 4.35.
TSVT's EV-to-Revenue is ranked better than 73.46% of 1036
companies
in the Biotechnology industry
Industry Median: 8.285
vs TSVT: 2.69
As of today (2024-05-09), 2seventy bio's stock price is $4.435.
2seventy bio's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.11. Therefore, 2seventy bio's PS Ratio for today is 2.10.
2seventy bio EV-to-Revenue Historical Data
The historical data trend for 2seventy bio's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of 2seventy bio's EV-to-Revenue
For the Biotechnology subindustry, 2seventy bio's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
2seventy bio's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 2seventy bio's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where 2seventy bio's EV-to-Revenue falls into.
2seventy bio's current Enterprise Value is $270.0 Mil.
2seventy bio's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $100.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
2seventy bio's share price for today is $4.435.
2seventy bio's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.11.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
2seventy bio EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of 2seventy bio's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSVT has been successfully added to your 